New study tracks Real-World results of ultrasound treatment for prostate cancer
NCT ID NCT07203482
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 21 times
Summary
This study is following 300 men with early-stage prostate cancer who choose to be treated with high-intensity focused ultrasound (HIFU). The goal is to track how well the treatment controls cancer and what side effects occur, especially regarding urinary and sexual function. Researchers hope to learn which patients benefit most and improve future care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NYU Langone Health - Cobble Hill
RECRUITINGBrooklyn, New York, 11201, United States
-
NYU Langone Health - Tisch Hospital
RECRUITINGNew York, New York, 10016, United States
Conditions
Explore the condition pages connected to this study.